• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7313
Device Problems Inflation Problem (1310); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Air Embolism (1697)
Event Date 03/08/2021
Event Type  Injury  
Event Description
It was reported that air embolism occurred.A percutaneous coronary intervention was performed on a severely calcified target lesion.A 2.50mm x 15mm nc emerge was advanced to the target lesion and was inflated at 16 atmospheres, and then was inflated several times for 20 atmospheres, but was not able to inflate again.There was a little air bubble in the vessel.It was noted that there was an expectation to see a hole in the balloon catheter, but a hole was not visible.No physical damage was observed to the device.The patient was reported to be fine and well and the procedure was completed with another of the same device.No patient complications resulted in relation to this event and the patient was reported to have been fully recovered.
 
Manufacturer Narrative
Device evaluated by mfr: returned product consisted of an nc emerge balloon catheter.The shaft, hypotube, tip and balloon were microscopically and visually examined.There were numerous kinks.There was contrast and blood in the inflation lumen and balloon, and blood in the guidewire lumen.The balloon was loosely folded.The device was prepped with an inflation device filled with water and connected to the inflation port to inflate the device.There was a 1mm shaft tear at the exit notch.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis found a shaft tear.
 
Event Description
It was reported that air embolism occurred.A percutaneous coronary intervention was performed on a severely calcified target lesion.A 2.50mm x 15mm nc emerge was advanced to the target lesion and was inflated at 16 atmospheres, and then was inflated several times for 20 atmospheres, but was not able to inflate again.There was a little air bubble in the vessel.It was noted that there was an expectation to see a hole in the balloon catheter, but a hole was not visible.No physical damage was observed to the device.The patient was reported to be fine and well and the procedure was completed with another of the same device.No patient complications resulted in relation to this event and the patient was reported to have been fully recovered.It was further reported that the 90 to 99% in stent restenosed target lesion was located in the severely calcified mid left anterior descending artery (lad).No patient complications were reported in relation to this event.
 
Event Description
It was reported that air embolism occurred.A percutaneous coronary intervention was performed on a severely calcified target lesion.A 2.50mm x 15mm nc emerge was advanced to the target lesion and was inflated at 16 atmospheres, and then was inflated several times for 20 atmospheres, but was not able to inflate again.There was a little air bubble in the vessel.It was noted that there was an expectation to see a hole in the balloon catheter, but a hole was not visible.No physical damage was observed to the device.The patient was reported to be fine and well and the procedure was completed with another of the same device.No patient complications resulted in relation to this event and the patient was reported to have been fully recovered.It was further reported that the 90 to 99% in stent restenosed target lesion was located in the severely calcified mid left anterior descending artery (lad).No patient complications were reported in relation to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11495785
MDR Text Key240098131
Report Number2134265-2021-03372
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 05/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/03/2022
Device Model Number7313
Device Catalogue Number7313
Device Lot Number0026292660
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/05/2021
Initial Date Manufacturer Received 03/09/2021
Initial Date FDA Received03/16/2021
Supplement Dates Manufacturer Received03/19/2021
04/30/2021
Supplement Dates FDA Received04/12/2021
05/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-